Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Archive

Multidisciplinary Epilepsy Center Opens at Hadassah University Medical Center

A new interdisciplinary center for the treatment of epilepsy in children and adults has opened at the Hadassah University Medical Center. A team of pediatric and adult neurologists, neurosurgeons, psychiatrists, neuropsychologists, radiologists, nuclear medicine experts, nurses, nutrition specialists, and researchers will help patients navigate this common, but complex disease. With the right treatment, 70 percent of patients with epilepsy become seizure free and are able to lead completely normal lives.

Patients who continue to suffer from seizures despite medical therapy can be helped through implantation of a pacemaker or other surgical procedures. "Many patients suffering from seizures (often for years) or from side effects of anticonvulsant therapy are not aware that there is a possibility of improving their condition" says Dr. Dana Ekstein from the Neurology Department at Hadassah, who coordinates the new Center's activities. "Therefore, it is extremely important," she notes, "to raise awareness in the general public and medical community about the need for an epilepsy specialty center at which advanced evaluation and treatment for even the most difficult cases are made possible." She adds that Hadassah's epilepsy center "holds itself to the highest standard in diagnosis and treatment of patients." In addition, Dr. Ekstein relates, the Center "supports high-level research in collaboration with researchers from the Hebrew University and other leading institutions worldwide."

Date: 4/15/2012


More hMedicine Stories




Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

   |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America